| Discuss rabies under following headings: Clinical manifestations with classification. (DCH 2025/1) 5 | P1 | 2025 |
| Discuss rabies under following headings: Post exposure prophylaxis in a case of dog bite. (DCH 2025/1) 5 | P1 | 2025 |
| Norwegian scabies. (DCH 2025/1) 5 | P1 | 2025 |
| Acrodermatitis enteropathica. (DCH 2025/1) 5 | P1 | 2025 |
| Brainstem Evoked Response Audiometry (BERA). (DCH 2025/1) 5 | P1 | 2025 |
| Retinopathy of Prematurity (ROP) screening. (DCH 2025/1) 5 | P1 | 2025 |
| Describe paediatric Systemic Lupus Erythematosus (SLE) under following headings:- Clinical manifestations. (DCH 2025/1) 3 | P1 | 2025 |
| Describe paediatric Systemic Lupus Erythematosus (SLE) under following headings:- Diagnostic criteria in SLE. (DCH 2025/1) 4 | P1 | 2025 |
| Describe paediatric Systemic Lupus Erythematosus (SLE) under following headings:- Management guidelines in SLE. (DCH 2025/1) 3 | P1 | 2025 |
| HEADSSS screening tool for psychosocial assessment in adolescents. (DCH 2025/1) 5 | P1 | 2025 |
| Cognitive behavioural therapy. (DCH 2025/1) 5 | P1 | 2025 |
| Congenital hypothyroidism. (DCH 2025/1) 5 | P1 | 2025 |
| Diabetes insipidus. (DCH 2025/1) 5 | P1 | 2025 |
| Fecal microbiota transplantation. (DCH 2025/1) 5 | P1 | 2025 |
| Capsule endoscopy. (DCH 2025/1) 5 | P1 | 2025 |
| Discuss congestive heart failure in children under following headings:- Definition. (DCH 2025/1) 1 | P1 | 2025 |
| Discuss congestive heart failure in children under following headings:- Clinical features. (DCH 2025/1) 3 | P1 | 2025 |
| Discuss congestive heart failure in children under following headings:- Common causes. (DCH 2025/1) 2 | P1 | 2025 |
| Discuss congestive heart failure in children under following headings:- Management. (DCH 2025/1) 4 | P1 | 2025 |
| Management of an episode of acute severe asthma in a 9-year-old girl. (DCH 2025/1) 5 | P1 | 2025 |
| Recurrent pneumonia in a 2-year-old child. (DCH 2025/1) 5 | P1 | 2025 |
| Discuss Wilson disease under following headings:- Genetics. (DCH 2025/1) 1 | P1 | 2025 |
| Discuss Wilson disease under following headings:- Clinical presentation. (DCH 2025/1) 3 | P1 | 2025 |
| Discuss Wilson disease under following headings:- Diagnostic evaluation. (DCH 2025/1) 3 | P1 | 2025 |
| Discuss Wilson disease under following headings:- Management. (DCH 2025/1) 3 | P1 | 2025 |
| Rashtriya Bal Swasthya Karyakram (RBSK) Programme. (DCH 2025/2) 5 | P2 | 2025 |
| Mothers Absolute Affection (MAA) Programme. (DCH 2025/2) 5 | P2 | 2025 |
| Eating disorders in childhood. (DCH 2025/2) 5 | P2 | 2025 |
| Tanner staging in adolescent females. (DCH 2025/2) 5 | P2 | 2025 |
| Preimplantation Genetic Diagnosis (PIGD). (DCH 2025/2) 5 | P2 | 2025 |
| Gene therapy in paediatric disorders. (DCH 2025/2) 5 | P2 | 2025 |
| Human Papilloma Virus Vaccine (HPV Vaccine). (DCH 2025/2) 5 | P2 | 2025 |
| Intensified Mission Indradhanush Programme. (DCH 2025/2) 5 | P2 | 2025 |
| Steroid Resistant Nephrotic Syndrome (SRNS) : Diagnosis. (DCH 2025/2) 2 | P2 | 2025 |
| Steroid Resistant Nephrotic Syndrome (SRNS) : Investigations. (DCH 2025/2) 2 | P2 | 2025 |
| Steroid Resistant Nephrotic Syndrome (SRNS) : Management. (DCH 2025/2) 6 | P2 | 2025 |
| Rapidly Progressive Glomerulonephritis (RPGN). (DCH 2025/2) 5 | P2 | 2025 |
| Role of new biomarkers in diagnosis of acute kidney injury (AKI). (DCH 2025/2) 5 | P2 | 2025 |
| Anaemia of prematurity. (DCH 2025/2) 5 | P2 | 2025 |
| Potential risks of blood transfusions in children. (DCH 2025/2) 5 | P2 | 2025 |
| Hemophagocytic Lymphohistiocytosis (HLH) : Classification. (DCH 2025/2) 1 | P2 | 2025 |
| Hemophagocytic Lymphohistiocytosis (HLH) : Clinical features. (DCH 2025/2) 2 | P2 | 2025 |
| Hemophagocytic Lymphohistiocytosis (HLH) : Diagnosis. (DCH 2025/2) 4 | P2 | 2025 |
| Hemophagocytic Lymphohistiocytosis (HLH) : Management. (DCH 2025/2) 3 | P2 | 2025 |
| Role of diet in drug resistant epilepsy. (DCH 2025/2) 5 | P2 | 2025 |
| New Onset Refractory Status Epilepticus (NORSE). (DCH 2025/2) 5 | P2 | 2025 |
| Paediatric Stroke: Classification. (DCH 2025/2) 1 | P2 | 2025 |
| Paediatric Stroke: Risk factors and causes. (DCH 2025/2) 2 | P2 | 2025 |
| Paediatric Stroke: Diagnostic evaluation. (DCH 2025/2) 3 | P2 | 2025 |
| Paediatric Stroke: Management. (DCH 2025/2) 4 | P2 | 2025 |
| Enumerate various indicators related to fetal death. (DCH 2025/3) 4 | P3 | 2025 |
| Write briefly on Poshan Abhiyan (National Nutrition Mission). (DCH 2025/3) 3 | P3 | 2025 |
| Standardized mortality ratio (SMR) and its importance in pediatrics. (DCH 2025/3) 3 | P3 | 2025 |
| Enumerate the technique and precautions while collecting blood samples for arterial blood gas analysis. (DCH 2025/3) 5 | P3 | 2025 |
| Causes of metabolic acidosis in a child. (DCH 2025/3) 5 | P3 | 2025 |
| Home Based Newborn Care program (HBNC). (DCH 2025/3) 4 | P3 | 2025 |
| Discuss the following in children between 0-18 years of age: (i) Parameters to detect undernutrition. [3] (ii) Parameters to detect overnutrition. (DCH 2025/3) 3 | P3 | 2025 |
| Role of Accredited Social Health Activist (ASHA) worker in neonatal and child health. (DCH 2025/3) 5 | P3 | 2025 |
| Home - based care for young child (HBYC). (DCH 2025/3) 5 | P3 | 2025 |
| Cluster randomized trial. (DCH 2025/3) 5 | P3 | 2025 |
| Components of patient Information sheet in study design. (DCH 2025/3) 5 | P3 | 2025 |
| Define brain death in neonate and in a child. (DCH 2025/3) 5 | P3 | 2025 |
| Physiological changes and principles of management of hyponatremia in a child. (DCH 2025/3) 5 | P3 | 2025 |
| Advantages and disadvantages of case-control study design. (DCH 2025/3) 5 | P3 | 2025 |
| Interpretation of linear correlation coefficient ‘r’. (DCH 2025/3) 5 | P3 | 2025 |
| Types of maltreatment of a child. (DCH 2025/3) 5 | P3 | 2025 |
| Adverse Events Following Immunisation (AEFI). (DCH 2025/3) 5 | P3 | 2025 |
| Relative risk and Odds ratio. (DCH 2025/3) 4 | P3 | 2025 |
| Enumerate types of Study design. (DCH 2025/3) 2 | P3 | 2025 |
| Role of Clinical Trials Registry of India (CTRI). (DCH 2025/3) 4 | P3 | 2025 |
| Babinski sign and various techniques to elicit it. (DCH 2025/3) 5 | P3 | 2025 |
| Systemic response to blood loss in a child. (DCH 2025/3) 5 | P3 | 2025 |